Isolation and characterization of hepatic mast cells from cholestatic rats

Laura Hargrove1, Allyson Graf-Eaton2, Lindsey Kennedy2

  • 1Digestive Disease Research Baylor Scott and White Health and Medicine, Temple, TX, USA.

Insights

Mast cells infiltrate cholestatic livers, releasing histamine that drives biliary proliferation and fibrosis. Isolating these mast cells (MCs) provides a tool to study their role in liver injury.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Mast cells (MCs) are immune cells involved in inflammatory responses.
  • Increased MCs are observed in cholestatic liver disease, suggesting a role in pathology.
  • Histamine released by MCs has been implicated in biliary proliferation.

Purpose of the Study:

  • To isolate and characterize mast cells from cholestatic rat livers.
  • To investigate the role of mast cells in regulating cholestatic liver injury and fibrosis.
  • To understand the paracrine mechanisms by which mast cells influence biliary pathologies.

Main Methods:

  • Bile duct ligation (BDL) in rats to induce cholestasis.
  • Isolation of liver cells using collagenase perfusion and magnetic bead separation.
  • Characterization of isolated mast cells by microscopy, flow cytometry, and gene expression analysis (qPCR).
  • In vitro assays assessing the effects of mast cell supernatants on cholangiocytes and hepatic stellate cells (HSCs).

Main Results:

  • Mast cells infiltrated rat livers post-BDL, accumulating around bile ducts.
  • A pure population of mature, functional mast cells was successfully isolated.
  • Isolated mast cells secreted histamine and expressed key mediators like chymase and tryptase.
  • Mast cell supernatants from cholestatic rats exacerbated biliary proliferation and fibrosis in vitro, an effect blocked by inhibiting histamine release.

Conclusions:

  • Mast cells are key regulators of liver injury and fibrosis in cholestasis.
  • Isolated mast cells serve as a valuable tool for studying their contribution to biliary pathologies.
  • Targeting mast cell mediators may offer therapeutic strategies for cholestatic liver diseases.

Related Concept Videos